Anti-Inflammatory Effects of Liriope platyphylla in LPS-Stimulated Macrophages and Endotoxemic Mice

Am J Chin Med. 2016;44(6):1127-1143. doi: 10.1142/S0192415X16500634. Epub 2016 Sep 15.

Abstract

In the present study, the anti-inflammatory and antisepticemic activities of a water extract of Liriope platyphylla (LP) were investigated. We first estimated the scavenging activity of DPPH and the hydroxyl radical and total phenolic contents of LP. Results indicated that LP, a rich source of phenolic compounds, showed a remarkable radical scavenging capacity. A MTT assay showed that LP treatment did not affect the toxicity against the RAW 264.7 macrophage cells, up to the concentration of 500[Formula: see text][Formula: see text]g/mL. Treatment of LP significantly attenuated the production of inflammatory mediators, such as nitric oxide (NO), interleukin-6 (IL-6), tumor-necrosis factor (TNF)-[Formula: see text] and prostaglandin (PG)E2 in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages cells. Moreover, LP contributed to the down-regulation of inducible NO synthase (iNOS) and TNF-[Formula: see text] mRNA expression, as well as cyclooxygenase-2 (COX-2) protein expression. A western blotting assay further showed that LP inhibited activation of mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-[Formula: see text]B. In an animal experiment using an LPS-induced septicemia model in C57BL/6 mice, oral administration of LP (40[Formula: see text]mg/kg body weight) markedly reduced the level of TNF-[Formula: see text] and IL-6 in serum and protected against LPS-induced lethal shock in mice. Taken together, the results of treatments of LP on inhibited LPS-induced inflammatory responses in both in vitro and in vivo models and indicate it may be a promising neutraceutical or medicinal agent to prevent or cure inflammation-related disease.

Keywords: Anti-Inflammation; Anti-Septicemia; Liriope platyphylla; MAPK; NF-κB.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents*
  • Anti-Inflammatory Agents*
  • Disease Models, Animal
  • Endotoxemia / drug therapy*
  • Endotoxemia / metabolism
  • Free Radical Scavengers / analysis
  • Free Radical Scavengers / isolation & purification
  • Inflammation Mediators / metabolism
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / adverse effects*
  • Liriope Plant / chemistry*
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Phenols / analysis
  • Phenols / isolation & purification
  • Phytotherapy*
  • Plant Extracts / administration & dosage
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use*
  • RAW 264.7 Cells
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Free Radical Scavengers
  • Inflammation Mediators
  • Interleukin-6
  • Lipopolysaccharides
  • Phenols
  • Plant Extracts
  • Tumor Necrosis Factor-alpha